论文信息 - Long-term overall survival (OS) with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies. - 字舞流文

Long-term overall survival (OS) with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies.

David C. Smith | R. Motzer | T. Choueiri | M. Atkins | E. Plimack | J. Sosman | C. Drake | M. Sznol | B. Rini | T. Kuzel | S. Topalian | U. Vaishampayan | D. McDermott | J. Powderly | S. George | H. Hammers | I. Waxman | Huanyu Zhao